Latest 10-K

View Latest 10-K

Stock Information

Symbol

Nasdaq: MOTS

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy. The Company’s flagship product is the Pure-Vu® System, a U.S. FDA cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques. The first generation of the Pure-Vu® System has received CE mark approval in Europe. The Pure-Vu® System is currently being introduced on a pilot basis in the U.S. market, and the Company is planning to initiate a commercial launch focused on the U.S. hospital market in 2019. Challenges with bowel preparation for inpatient colonoscopy represent a significant area of unmet need that directly affects clinical outcomes and increases the cost of care in a market segment that comprises approximately 1.5 million annual procedures in the U.S. and approximately 4 million annual procedures worldwide. Motus GI believes the Pure-Vu® System may improve outcomes and lower costs for hospitals by reducing the time to successful colonoscopy, minimizing delayed and incomplete procedures, and improving the quality of an exam. In clinical studies to date, the Pure-Vu® System significantly increased the number of patients with an adequate cleansing level, according to the Boston Bowel Preparation Scale Score, a validated assessment instrument.

Leadership

Our people are our backbone. Touting years of experience in a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Motus GI Holdings, Inc.
1301 E. Broward Blvd.
Suite 310
Fort Lauderdale, FL 33301
T: 954-541-8000
F: 954-541-8265
ir@motusgi.com

Investor Relations

LifeSci Advisors
Bob Yedid
Managing Director
T: 646-597-6989
bob@lifesciadvisors.com

Transfer Agent

Continental Stock Transfer & Trust
1 State Street
30th Floor
New York, NY 10004
T: 800-509-5586
cstmail@continentalstock.com
www.continentalstock.com